C108H132F6N34O4 — CID 167620703
1-[4-[3,5-dimethyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-5-fluoro-N-methylbenzimidazol-2-amine;(3R)-4-[6-(3,5-dimethyl-1-piperidin-4-ylpyrazol-4-yl)-2-(1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;1-[4-(3,5-dimethyl-1-piperidin-4-ylpyrazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-5-fluorobenzimidazol-2-amine;5-fluoro-N-methyl-1-[4-[(3R)-3-methylmorpholin-4-yl]-6-[5-methyl-1-piperidin-4-yl-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-yl]benzimidazol-2-amine (PubChem CID 167620703) has the molecular formula C108H132F6N34O4 and a molecular weight of 2084.47 g/mol. Its IUPAC name is 1-[4-[3,5-dimethyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-5-fluoro-N-methylbenzimidazol-2-amine;(3R)-4-[6-(3,5-dimethyl-1-piperidin-4-ylpyrazol-4-yl)-2-(1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;1-[4-(3,5-dimethyl-1-piperidin-4-ylpyrazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-5-fluorobenzimidazol-2-amine;5-fluoro-N-methyl-1-[4-[(3R)-3-methylmorpholin-4-yl]-6-[5-methyl-1-piperidin-4-yl-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-yl]benzimidazol-2-amine.
| Compound Name | 1-[4-[3,5-dimethyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-5-fluoro-N-methylbenzimidazol-2-amine;(3R)-4-[6-(3,5-dimethyl-1-piperidin-4-ylpyrazol-4-yl)-2-(1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;1-[4-(3,5-dimethyl-1-piperidin-4-ylpyrazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-5-fluorobenzimidazol-2-amine;5-fluoro-N-methyl-1-[4-[(3R)-3-methylmorpholin-4-yl]-6-[5-methyl-1-piperidin-4-yl-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-yl]benzimidazol-2-amine |
|---|---|
| PubChem CID | 167620703 |
| Molecular Formula | C108H132F6N34O4 |
| Molecular Weight | 2084.47 g/mol |
| Exact Mass | 2083.11 |
| IUPAC Name | 1-[4-[3,5-dimethyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-5-fluoro-N-methylbenzimidazol-2-amine;(3R)-4-[6-(3,5-dimethyl-1-piperidin-4-ylpyrazol-4-yl)-2-(1H-indol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;1-[4-(3,5-dimethyl-1-piperidin-4-ylpyrazol-4-yl)-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]-5-fluorobenzimidazol-2-amine;5-fluoro-N-methyl-1-[4-[(3R)-3-methylmorpholin-4-yl]-6-[5-methyl-1-piperidin-4-yl-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-yl]benzimidazol-2-amine |
| SMILES | CNc1nc2cc(F)ccc2n1-c1nc(-c2c(C(F)(F)F)nn(C3CCNCC3)c2C)cc(N2CCOC[C@H]2C)n1.CNc1nc2cc(F)ccc2n1-c1nc(-c2c(C)nn(C3CCN(C)CC3)c2C)cc(N2CCOC[C@H]2C)n1.Cc1nn(C2CCNCC2)c(C)c1-c1cc(N2CCOC[C@H]2C)nc(-c2cccc3[nH]ccc23)n1.Cc1nn(C2CCNCC2)c(C)c1-c1cc(N2CCOC[C@H]2C)nc(-n2c(N)nc3cc(F)ccc32)n1 |
| InChI | InChI=1S/C28H36FN9O.C27H31F4N9O.C27H33N7O.C26H32FN9O/c1-17-16-39-13-12-36(17)25-15-23(26-18(2)34-38(19(26)3)21-8-10-35(5)11-9-21)32-28(33-25)37-24-7-6-20(29)14-22(24)31-27(37)30-4;1-15-14-41-11-10-38(15)22-13-20(23-16(2)40(18-6-8-33-9-7-18)37-24(23)27(29,30)31)35-26(36-22)39-21-5-4-17(28)12-19(21)34-25(39)32-3;1-17-16-35-14-13-33(17)25-15-24(26-18(2)32-34(19(26)3)20-7-10-28-11-8-20)30-27(31-25)22-5-4-6-23-21(22)9-12-29-23;1-15-14-37-11-10-34(15)23-13-21(24-16(2)33-36(17(24)3)19-6-8-29-9-7-19)31-26(32-23)35-22-5-4-18(27)12-20(22)30-25(35)28/h6-7,14-15,17,21H,8-13,16H2,1-5H3,(H,30,31);4-5,12-13,15,18,33H,6-11,14H2,1-3H3,(H,32,34);4-6,9,12,15,17,20,28-29H,7-8,10-11,13-14,16H2,1-3H3;4-5,12-13,15,19,29H,6-11,14H2,1-3H3,(H2,28,30)/t17-;15-;17-;15-/m1111/s1 |
| InChIKey | MJYQVZQMCUSHIU-ZVSPTTMSSA-N |
| XLogP | 15.73 |
| TPSA | 382.94 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 152 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2084.47 |
| LogP ≤ 5 | 15.73 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 37 |